Individual tests

Preeclampsia is a high blood pressure (hypertension) disorder that can occur after the 20th week of pregnancy. Complications of preeclampsia may include: fetal growth restriction, preterm birth, and placental abruption. PlGF assay, in conjunction with sFlt-1 assay, other diagnostic tests, and clinical information, is for use in diagnosing preeclampsia.
Preeclampsia is a high blood pressure (hypertension) disorder that can occur after the 20th week of pregnancy. Complications of preeclampsia may include fetal growth restriction, preterm birth, and placental abruption. The PlGF assay is used with the sFlt-1 assay, other diagnostic tests, and clinical information to diagnose preeclampsia.
Preeclampsia is a high blood pressure (hypertension) disorder that can occur after the 20th week of pregnancy. Complications of preeclampsia may include: fetal growth restriction, preterm birth, and placental abruption. PlGF assay, in conjunction with sFlt-1 assay, other diagnostic tests, and clinical information, is for use in diagnosing preeclampsia.
Our semen analysis uses the new FDA-certified automated semen analysis system, SQA-IQ. The evaluation criteria are based on the latest WHO 6th Edition for Human Semen guidelines. This test determines male fertility status based on testing semen samples. Blood tests also need to be done to comprehensively analyse male infertility.
Second-trimester prenatal screening includes several blood tests that assess the risk of having a baby with certain genetic conditions or birth defects. Screening is usually done between the 14th and 22nd weeks of pregnancy (the 16th to 18th is ideal). A triple test includes AFP, hCG, and Estriol. Any abnormal result requires more testing. Usually, an ultrasound, or even an amniocentesis, may be needed for an accurate diagnosis.
loading.svg